dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology GLP-1 Receptor Agonists Have better

GLUTATHIONE A potent antioxidant that helps target photoaging, oxidative stress, and reduces the concerns associated with exposure to free radicals

Fecal microbiota transplantation in clinical practice: present controversies and future prospects

While clinical trials are underway including the Mucoactives in Acute Respiratory failure: Carbocisteine and Hypertonic saline (MARCH) trial which is comparing the efficacy of carbocisteine and/or hypertonic versus standard care in critically unwell adults with a primary outcome of ventilator dependency time [154, 155], mechanistic exploration is necessary to identify the correct mucolytic for the correct patient given recent availability of rapid rheometers and development of multi-omics data analysis supported by artificial intelligence, future research should be aiming to individualise of the prescription and administration of currently used mucolytics matching them to mucus phenotypes (Fig

ROS-sensitive Crocin-loaded chitosan microspheres for lung targeting and attenuation of radiation-induced lung injury

(2) the activity of dimerized aMD4 was almost independent of the linker length (Fig